Amgen Raises 2026 Earnings Guidance Following Strong Q3 Revenue Growth
Amgen (AMGN) reported a strong third quarter with total revenues increasing 8% year-over-year to $10.4 billion. The company's performance was bolstered by its six key growth drivers, which saw a significant 27% year-over-year increase and now account for over 70% of the firm's revenue stream. Based on this momentum, Amgen has raised its full-year 2026 non-GAAP earnings per share (EPS) guidance to a range of $22.90–$23.70. The company also projects total 2026 revenues to fall between $38.9 billion and $39.7 billion, signaling confidence in its long-term growth trajectory.
Tickers: $AMGN